© 1995 American Heart Association, Inc.
Articles |
cGMP and Atrial Natriuretic Factor Regulate Cell Volume of Rabbit Atrial Myocytes
From the Departments of Internal Medicine and Physiology, Medical College of Virginia, Virginia Commonwealth University, Richmond.
Correspondence to Dr C.M. Baumgarten, Department of Physiology, Medical College of Virginia, Richmond, VA 23298-0551. E-mail baumgart@gems.vcu.edu.
Abstract Atrial natriuretic factor (ANF) reduces the volume of atrial myocytes by inhibiting Na+/K+/2Cl- cotransport. We determined the role of cGMP and cAMP in ANF-induced shrinkage by using digital video microscopy to measure cell volume; volumes are reported relative to control. ANF (1 µmol/L) reversibly reduced atrial cell volume from 1.0 to 0.915±0.005 (mean±SEM). This effect was mimicked by 10 µmol/L 8-bromo-cGMP (8-Br-cGMP), which decreased myocyte volume to 0.894±0.007 with an ED50 of 0.99±0.05 µmol/L. In contrast, 100 µmol/L 8-bromo-cAMP (8-Br-cAMP) did not affect volume, and activating the cAMP pathway with 100 µmol/L 8-Br-cAMP did not alter the volume decrease caused by 8-Br-cGMP or ANF. Inhibition of Na+/K+/2Cl- cotransport with bumetanide (1 µmol/L) also reduced cell volume and prevented further shrinkage on subsequent exposure to 8-Br-cGMP. Similarly, 8-Br-cGMP (10 µmol/L) prevented further shrinkage by ANF. Block of Na+-H+ exchange, a participant in volume regulation in other cells, did not alter the response to 8-Br-cGMP. More evidence implicating cGMP was obtained by altering its metabolism. LY83583 (10 µmol/L), a guanylate cyclase inhibitor, blocked ANF-induced cell shrinkage. Zaprinast (100 µmol/L), a cGMP-specific phosphodiesterase inhibitor, markedly potentiated the effect of a threshold concentration of ANF (0.01 µmol/L). The actions of ANF, LY83583, and zaprinast on cGMP levels were verified by radioimmunoassay. These data strongly support the idea that the cGMP cascade is the intracellular signaling pathway responsible for ANF-induced atrial cell shrinkage. ANF activates guanylate cyclase, and the subsequent rise in cGMP inhibits Na+/K+/2Cl- cotransport. This reduces the uptake of osmolytes, and cell shrinkage follows. In addition, LY83583 caused a small swelling and zaprinast caused a small shrinkage in the absence of other agents. This suggests that physiological levels of cGMP partially inhibit Na+/K+/2Cl- cotransport and help set isosmotic cell volume. It is proposed that ANF-induced elevation of atrial cGMP and the ensuing cell shrinkage serve as a negative-feedback mechanism limiting stretch-induced ANF secretion.
Key Words: atrial natriuretic peptide • cell volume • Na+/K+/2Cl- cotransport • cGMP • phosphodiesterase
This article has been cited by other articles:
 |
|
 |
|
  W. C De Mello Intracellular and extracellular renin have opposite effects on the regulation of heart cell volume. Implications for myocardial ischaemia Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 112 - 118. [Abstract] [PDF]
|
|
|
|
 |
|
 R. C. Massaro, L. W. Lee, A. B. Patel, D. S. Wu, M.-J. Yu, B. N. Scott, D. A. Schooley, K. M. Schegg, and K. W. Beyenbach The mechanism of action of the antidiuretic peptide Tenmo ADFa in Malpighian tubules of Aedes aegypti J. Exp. Biol., July 15, 2004; 207(16): 2877 - 2888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Davis, J. J. Rychak, B. Hosticka, S. C. Davis, J. E. John III, A. L. Tucker, P. M. Norris, and J. R. Moorman A novel method for measuring dynamic changes in cell volume J Appl Physiol, May 1, 2004; 96(5): 1886 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Akar, T. H. Everett, R. Ho, J. Craft, D. E. Haines, A. P. Somlyo, and A. V. Somlyo Intracellular Chloride Accumulation and Subcellular Elemental Distribution During Atrial Fibrillation Circulation, April 8, 2003; 107(13): 1810 - 1815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kishimoto, K. Rossi, and D. L. Garbers A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy PNAS, February 8, 2001; (2001) 51625598. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Chusho, Y. Ogawa, N. Tamura, M. Suda, A. Yasoda, T. Miyazawa, I. Kishimoto, Y. Komatsu, H. Itoh, K. Tanaka, et al. Genetic Models Reveal That Brain Natriuretic Peptide Can Signal through Different Tissue-Specific Receptor-Mediated Pathways Endocrinology, October 1, 2000; 141(10): 3807 - 3813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Hume, D. Duan, M. L. Collier, J. Yamazaki, and B. Horowitz Anion Transport in Heart Physiol Rev, January 1, 2000; 80(1): 31 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Russell Sodium-Potassium-Chloride Cotransport Physiol Rev, January 1, 2000; 80(1): 211 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. LANG, G. L. BUSCH, M. RITTER, H. VOLKL, S. WALDEGGER, E. GULBINS, and D. HAUSSINGER Functional Significance of Cell Volume Regulatory Mechanisms Physiol Rev, January 1, 1998; 78(1): 247 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Mihailidou, K. A. Buhagiar, and H. H. Rasmussen Na+ influx and Na+-K+ pump activation during short-term exposure of cardiac myocytes to aldosterone Am J Physiol Cell Physiol, January 1, 1998; 274(1): C175 - C181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A Brown, R. A.D Rutherford, D. J.R Nunez, John Wharton, D. G Lowe, and M. R Wilkins Downregulation of natriuretic peptide C-receptor protein in the hypertrophied ventricle of the aortovenocaval fistula rat Cardiovasc Res, December 1, 1997; 36(3): 363 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-F. Wu, N. H. Bishopric, and R. E. Pratt Atrial Natriuretic Peptide Induces Apoptosis in Neonatal Rat Cardiac Myocytes J. Biol. Chem., June 6, 1997; 272(23): 14860 - 14866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Kishimoto, K. Rossi, and D. L. Garbers A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy PNAS, February 27, 2001; 98(5): 2703 - 2706. [Abstract] [Full Text] [PDF]
|
|